Role of antibiotic line locks in the prevention of tunnelled haemodialysis catheter infection: a double-blind, randomised controlled trial

ISRCTN ISRCTN32633497
DOI https://doi.org/10.1186/ISRCTN32633497
Protocol serial number 08/05
Sponsor Wirral Hospitals NHS Trust (UK)
Funder Funded within our department
Submission date
07/06/2004
Registration date
26/09/2005
Last edited
05/02/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Peter McClelland
Scientific

Arrowe Park Hospital
Liverpool
CH49 5PE
United Kingdom

Study information

Primary study designInterventional
Study designRandomised double blind controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesThe null hypothesis to be tested is that antibiotic line locks will not reduce the incidence of catheter related blood stream
infection compared with the standard practice of catheter filling with heparin alone.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHaemodialysis catheter related sepsis
InterventionControl group will receive usual heparin line locks between dialysis sessions.
Intervention group will receive a line lock containing heparin, vancomycin and gentamicin.
Intervention typeOther
Primary outcome measure(s)

The time in days from insertion of tunnelled haemodialysis catheter (THDC) to first catheter related infection (CRI). CRI will be diagnosed by a combination of clinical suspicion, raised temperature, blood tests (white
cell count and inflammatory markers) and the results of blood cultures from the tunnelled
haemodialysis catheter (THDC) and from a peripheral vein.

Key secondary outcome measure(s)

1. Mean haemoglobin concentration
2. Mean erythropoietin dose adjusted for body mass
3. Mean serum albumin concentration
4. Mean number of days in hospital per annum
5. Mean number of hospital admissions per annum

Completion date01/08/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration80
Key inclusion criteriaAll patients requiring insertion of a tunnelled haemodialysis catheter (THDC) for haemodialysis.
Key exclusion criteria1. Patients on prolonged courses of antibiotics (oral or parenteral) i.e. for greater than 2 weeks. (This may reduce the incidence of CRI and therefore confound the results).
2. Patients with a known allergy to vancomycin or gentamicin
3. Patients known to suffer from heparin induced thrombocytopenia
4. Patients who are pregnant or plan to become pregnant. (Vancomycin and gentamicin are potentially toxic to the fetus).
5. An inability to provide informed consent to participation in the study
Date of first enrolment01/08/2004
Date of final enrolment01/08/2006

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Arrowe Park Hospital
Liverpool
CH49 5PE
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan